Using PI3K and MEK modulators in treatments of cancer

Details for Australian Patent Application No. 2007284562 (hide)

Owner Exelixis, Inc.

Inventors Laird, A. Douglas; Martini, JeanFrancois A.; Lamb, Peter; Aftab, Dana T.

Agent Davies Collison Cave

Pub. Number AU-A-2007284562

PCT Pub. Number WO2008/021389

Priority 60/838,307 16.08.06 US

Filing date 16 August 2007

Wipo publication date 21 February 2008

International Classifications

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021389 Priority application(s): WO2008/021389

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284570-Automated system for formulating radiopharmaceuticals

2007284553-Swinging agitator for a gypsum calcining apparatus and the like